Current Treatment for Gonorrhea
Uncomplicated Gonococcal Infections
- The Centers for Disease Control and Prevention recommends ceftriaxone 250 mg IM as a single dose plus azithromycin 1g orally in a single dose as the first-line treatment regimen for uncomplicated gonorrhea 1, 2
- Spectinomycin 2g IM in a single dose is a useful alternative for patients who cannot tolerate cephalosporins and quinolones 1, 3
- Fluoroquinolones are no longer recommended due to widespread resistance 1, 2
- Test of cure is not needed for uncomplicated infections treated with recommended regimens, but all sexual partners within 60 days should be evaluated and treated 4
Pharyngeal Gonococcal Infections
- Pharyngeal infections are more difficult to eradicate than urogenital or rectal infections 5, 3
- The recommended treatment for pharyngeal infections is ceftriaxone 250 mg IM in a single dose plus azithromycin 1g orally in a single dose 1, 3
Special Considerations
- Surveillance for antimicrobial resistance is crucial for guiding therapy recommendations, and the Gonococcal Isolate Surveillance Project (GISP) monitors resistance patterns in the US 1
- Clinicians should perform culture and susceptibility testing if treatment failure occurs 1
- Treatment recommendations for HIV co-infected patients are the same as for HIV-negative patients 1